3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Gastrointestinal Neoplasms
2
Colorectal Neoplasms
2
Cholangiocarcinoma
2
Vomiting
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Pain, Postoperative
1
Pain
1
Oropharyngeal Neoplasms
1
Neuralgia
1
Neoplasms
1
Neoplasm Metastasis
1
Nausea
1
Liver Neoplasms
1
Intestinal Diseases
1
Inflammatory Bowel Diseases
1
Gastrointestinal Diseases
1
Esophageal Neoplasms
1
Digestive System Diseases
1
Crohn Disease
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Anus Neoplasms
1
Adenocarcinoma
1
Interventions
Sutures
1
Surveys and Questionnaires
1
Surgical Instruments
1
Ringer's Lactate
1
Proctocolectomy, Restorative
1
Photoplethysmography
1
Phlebotomy
1
Lysine Acetyltransferase 5
1
Laparoscopy
1
Infliximab
1
Hydroxyethyl Starch Derivatives
1
Educational Status
1
Dexamethasone
1
Calcium Dobesilate
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Crohn Disease
×
Calcium Dobesilate
×
Gastrointestinal
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts